DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
227	オスラー病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01752049 (ClinicalTrials.gov)	May 2013	14/12/2012	Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept	Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept	Hereditary Hemorrhagic Telangiectasia	Drug: Topical timolol maleate;Drug: placebo saline drops	St. Michael's Hospital, Toronto	University of California, San Francisco;The Hospital for Sick Children;University of Toronto;Sunnybrook Health Sciences Centre;Ryerson University;National Institute of Neurological Disorders and Stroke (NINDS)	Completed	18 Years	N/A	All	5	N/A	Canada

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01752049
(ClinicalTrials.gov)

May 2013

14/12/2012

Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept

Hereditary Hemorrhagic Telangiectasia

Drug: Topical timolol maleate;Drug: placebo saline drops

St. Michael's Hospital, Toronto

University of California, San Francisco;The Hospital for Sick Children;University of Toronto;Sunnybrook Health Sciences Centre;Ryerson University;National Institute of Neurological Disorders and Stroke (NINDS)

Completed

18 Years

N/A

All

N/A

Canada